Immix Biopharma, Inc. — All Filings
212 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
FWP
RW
RW WD
S-1
S-1/A
S-3
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| CORRESP | — | 0001493152-21-025618 | Oct 15, 2021 | — |
| UPLOAD | — | 0000000000-21-012367 | Oct 13, 2021 | — |
| SEC STAFF LETTER | — | 9999999997-21-005222 | Oct 13, 2021 | — |
| CORRESP | — | 0001493152-21-024815 | Oct 6, 2021 | — |
| S-1/A | — | 0001493152-21-024809 | Oct 6, 2021 | — |
| UPLOAD | — | 0000000000-21-011755 | Sep 27, 2021 | — |
| S-1 | — | 0001493152-21-022940 | Sep 17, 2021 | — |
| CORRESP | — | 0001493152-21-022942 | Sep 16, 2021 | — |
| UPLOAD | — | 0000000000-21-010045 | Aug 16, 2021 | — |
| DRSLTR | — | 0001493152-21-017292 | Jul 20, 2021 | — |
| DRS | — | 0001493152-21-017290 | Jul 20, 2021 | — |